Death domain receptors and their role in cell demise

Journal of Interferon and Cytokine Research

Volumn 18, Issue 7, 1998, Pages 439-450

  Singh, Arjun ^a   Ni, Jian ^b   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CELL PROTEIN; CELL SURFACE RECEPTOR; FAS LIGAND; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; PROTEINASE; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; ENZYME ACTIVATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW;

EID: 0031904426     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.439     Document Type: Review

References (129)

1. TEWARI, M., QUAN, L.T., O'ROURKE, K., DESNOYERS, S., ZENG, Z., BEIDLER, D.R., POIRIER, G.G., SALVESEN, G.S., and DIXIT, V.M. (1995). Yama/CPP32b, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81, 801-809.
2. PRASAD, K.V.S., AO, Z., YOON, Y., WU, M.X., RIZK, M., JACQUOT, S., and SCHLOSSMAN, S.F. (1997). CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA 94, 6346-6357.
3. XL and initiates cell death. Proc. Natl. Acad. Sci. USA 94, 11333-11338.
4. TAKAYAMA, S., KOCHEL, K., IRIE, S., INAZAWA, J., ABE, T., SATO, T., DRUCK, T., HUEBNER, K., and REED, J.C. (1996). Cloning of cDNAs encoding the human BAG1 protein and localization of the human BAG1 gene to chromosome 9p12. Genomics 35, 484-488.
5. BOLDIN, M.P., GONCHAROV, T.M., GOLTSEV, Y.V., and WALLACH, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803-815.
6. KERR, J.F.R., WYLLIE, A.H., and CURRIE, A.R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
7. DARNAY, B.G., and AGGARWAL, B.B. (1997). Early events in TNF signaling: a story of associations and dissociations. J. Leukocyte Biol. 61, 559-566.
8. LIU, X., KIM, C.N., YANG, J., JEMMERSON, R., and WANG, X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157.
9. LI, P., NIJHAWAN, D., BUDIHARDJO, I., SRINIVASULA, S.M., AHMAD, M., ALNEMRI, E.S., and WANG, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
10. TRAUTH, B.C., KLAS, C., PETERS, A.M., MATZKU, S., MOLLER, P., FALK, W., DEBATIN, K.M., and KRAMMER, P.H. (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305.
11. OEHM, A., BEHRMANN, I., FALK, W., PAWLITA, M., MAIER, G., KLAS, C., LI-WEBER, M., RICHARDS, S., DHEIN, J., TRAUTH, B.C., PONSTING, H., and KRAMMER, P.H. (1992). Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267, 10709-10715.
12. PITTI, R.M., MARSTERS, S.A., RUPPERT, S., DONAHUE, C.J., MOORE, A., and ASHKENAZI, A. (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687-12690.
13. MARSTERS, S.A., SHERIDAN, J.P., DONAHUE, C.J., PITTI, R.M., GRAY, C.L., GODDARD, A.D., BAUER, K.D., and ASHKENAZI, A. (1996). Apo-3, a new member of the tumor necrosis factor family, contains a death domain and activates apoptosis and NF-κB. (1996). Curr. Biol. 6, 1669-1676.
14. NICHOLSON, D.W., ALL, A., THORNBERRY, N.A., VAILLANCOURT, J.P., DING, C.K., GALLANT, M., GAREAU, Y., GRIFFIN, P.R., LABELLE, M., LAZEBNIK, Y.A., MUNDAY, N.A., RAJU, S.M., SMULSON, M.E., YAMIN, T.-T., YU, V.L., and MILLER, D.K. (1995). Identification and inhibition of the ICE/ced-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
15. HSU, H., SOLOVYEV, I., COLOMBERO, A., ELLIOTT, R., KELLEY, M., and BOYLE, W.J. (1996). ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J. Biol. Chem. 272, 13471-13474.
16. TSUJIMOTO, Y., JAFFE, E., COSSMAN, J., GORHAM, J., NOWELL, P.C., and CROCE, C.M. (1985). Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;4) chromosome translocation. Nature 315, 340-343.
17. TSUJIMOTO, Y., and CROCE, C.M. (1986). Analysis of structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83, 5214-5218.
18. SATO, T., IRIE, S., and REED, J.C. (1995). A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40. FEBS Lett. 358, 113-118.
19. KISCHKEL, F.C., HELLBARDT, S., BEHRMANN, I., GERMER, M., PAWLITA, M., KRAMMER, P.H., and PETER, M.E. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signalling complex (DISC) with the receptor. EMBO J. 14, 5579-55705.
20. MUZIO, M., CHINNAIYAN, A.M., KISCHKEL, F.C., O'ROURKE, K., SHEVCHENKO, A., NI, J., SCAFFIDI, C., BRETZ, J.D., ZHANG, M., GENTZ, R., MANN, M., KRAMMER, P.H., PETER, M.E., and DIXIT, V.M. (1996). FLICE, a novel FADD- homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85, 817-827.
21. GOLTSEV, Y.V., KOVALENKO, A.V., ARNOLD, E., VARFOLOMEEV, E.E., BRODIANSKII, V.M., and WALLACH, D. (1997). CASH, a novel caspase homologous with death effector domains. J. Biol. Chem. 272, 19641-19644.
22. SALVESEN, G.S., and DIXIT, V.M. (1997). Caspases: intracellular signaling by proteolysis. Cell 91, 443-446.
23. HUMKE, E.W., JIAN NI, J., and DIXIT, V.M. (1998). ERICE, a novel FLICE activatable caspase. J. Biol. Chem. 273, 15702-15707.
24. VAN DE CRAEN, M., VANDENABEELE, P., DECLERCQ, W., VAN DEN BRANDE, I., VAN LOO, G., MOLEMANS, F., SCHOTTE, P., VAN CRIEKINGE, W., BEYAERT, R., and FIERS, W. (1997). Characterization of seven murine caspase family members. FEBS Lett. 403, 61-69.
25. SHU, H.-B., HALPIN, D.R., and GOEDDEL, D.V. (1997). Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6, 757-763.
26. SHU, H.-B., TAKEUCHI, M., and GOEDDEL, D.V. (1996). The tumor necrosis factor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc. Natl. Acad. Sci. USA 93, 13973-13978.
27. INOHARA, N., KOSEKI, T., HU, Y., CHEN, S., and NUNEZ, C. (1997). CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA 94, 10717-10722.
28. LIPPKE, J.A., GU, Y., SARNECKI, C., CARON, P.R., and SU, M.S.-S. (1996). Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J. Biol. Chem. 271, 1825-1828.
29. FERNANDES-ALNEMRI, T., LITWACK, G., and ALNEMRI, E.S. (1994). CPP32. a novel human apoptotic protein with homology to Caenorhabditis elegans cells death protein Ced-3 and mammalian interleukin-1B-converting enzyme. J. Biol. Chem. 269, 30761-30764.
30. AHMAD, M., SRINIVASULA, S.M., WANG, L., TALANIAN, R.V., LITWACK, G., FERNANDES-ALNEMRI, T., and ALNEMRI, E.S. (1997). CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res. 57, 615-619.
31. CHENG, G., CLEARY, A.M., YE, Z.S., HONG, D.I., LEDERMAN, S., and BALTIMORE, D. (1995). Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494-1498.
32. SHERIDAN, J.P., MARSTERS, S.A., PITTI, R.M., GURNEY, A., SKUBATCH, M., BALDWIN, D., RAMAKRISHNAN, L., GRAY, C.L., BAKER, K., WOOD, W.I., GODDARD, A.D., GODOWSKI, P., and ASHKENAZI, A. (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818-821.
33. MARSTERS, S.A., SHERIDAN, J.P., PITTI, R.M., HUANG, A., SKUBATCH, M., BALDWIN, D., YUAN, J., GURNEY, A., GODDARD, A.D., GODOWSKI, P., and ASHKENAZI, A. (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7, 1003-1006.
34. CHINNAIYAN, A.M., O'ROURKE, K., YU, G.-L., LYONS, R.H., GARG, M., DUAN, D.R., XING, L., GENTZ, R., NI, J., and DIXIT, V.M. (1996). Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274, 990-992.
35. PAN, G., O'ROURKE, K., CHINNAIYAN, A.M., GENTZ, R., EBNER, R., NI, J., and DIXIT, V.M. (1997). The receptor for the cytotoxic ligand TRAIL. Science 276, 111-113.
36. SCHNEIDER, P., THOME, M., BURNS, K., BOOMER, J.-L., HOFMANN, K., KATAOKA, T., HOLLER, N., and TSCHOPP, J. (1997). TRAIL receptors l (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7, 831-836.
37. MACFARLANE, M., AHMAD, M., SRINIVASULA, S.M., FERNANDES-ALNEMRI, T., COHEN, G.M., and ALNEMRI, E.S. (1997). Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272, 25417-25380.
38. CHAUDHARY, P.M., EBY, M., JASMIN, A., BOOKWALTER, A., MURRAY, J., and HOOD, L. (1997). Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate NF-κB pathway. Immunity 7, 821-830.
39. CHINNAIYAN, A.M., O'ROURKE, K., TEWARI, M., and DIXIT, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domains of Fas and initiates apoptosis. Cell 81, 505-572.
40. CHU, K., NIU, X., and WILLIAMS, L.T. (1995). A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc. Natl. Acad. Sci. USA 92, 11894-11898.
41. ADAM-KLAGES, S., ADAM, D., WIEGMANN, K., STRUVE, S., KOLANUS, W., SCHNEIDER-MERGENER, J., and KRONKE, M. (1996). FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86, 937-947.
42. YONEHARA, S., ISHII, A., and YONEHARA, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
43. ITOH, N., YONEHARA, S., ISHII, A., YONEHARA, M., MIZUSHIMA, S.-I., SAMESHIMA, M., HASE, A., SETO, Y., and NAGATA, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
44. SRINIVASULA, S.M., AHMAD, M., OTTILIE, S., BULLRICH, F., BANKS, S., WANG, Y., FERNANDES-ALNEMRI, T., CROCE, C.M., LITWACK, G., TOMASELLI, K.J., ARMSTRONG, R.C., and ALNEMRI, E.S. (1997). FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272, 18542-18545.
45. VINCENZ, C., and DIXIT, V.M. (1997). Fas-associated death domain protein interleukin-1β-converting enzyme 2 (FLICE2), an ICE/Ced-3 homologue, is proximally involved in CD95- and p55-mediated death signaling. J. Biol. Chem. 272, 6578-6583.
46. IRMLER, M., THOME, M., HAHNE, M., SCHNEIDER, P., HOFMANN, K., STEINER, V., BOOMER, J.L., SCHROTER, M., BURNS, K., MATTMANN, C., RIMOLDI, D., FRENCH, L.E., and TSCHOPP, J. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195.
47. MONTGOMERY, R.I., WARNER, M.S., LUM, B.J., and SPEAR, P.G. (1996). Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427-436.
48. BLACK, R.A., KRONHEIM, S.R., CANTRELL, M., DEELEY, M.C., MARCH, C.J., PRICKETT, K.S., WIGNALL, J., CONLON, P.J., COSMAN, D., HOPP, T.P., and MOCHIZUKI, D.Y. (1988). Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor. J. Biol. Chem. 263, 9437-9442.
49. DUAN, H., CHINNAIYAN, A.M., HUDSON, P.L., WING, J.P., HE, W.W., and DIXIT, V.M. (1996). ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 271, 1621-1625.
50. DUAN, H., ORTH, K., CHINNAIYAN, A.M., POIRIER, G.G., FROELICH, C.J., HE, W.-W., and DIXIT, V.M. (1996). ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J. Biol. Chem. 271, 16720-16724.
51. relIII, members of the ICE/ced-3 family of cysteine proteases. J. Biol. Chem. 270, 15870-15876.
52. WANG, L., MIURA, M., BERGERON, L., ZHU, H., and YUAN, J. (1994). Ich-1, an ICE/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-750.
53. KAMENS, J., PASKIND, M., HUGUNIN, M., TALANIAN, R.V., ALLEN, H., BANACH, D., BUMP, N., HACKETT, M., JOHNSTON, C.G., LI, P., MANKOVICH, J.A., TERRANOVA, M., and GHAYUR, T. (1995). Identification and characterization of ICH-2, a novel member of the interleukin-1β-converting enzyme family of cysteine proteases. J. Biol. Chem. 270, 15250-15256.
54. HU, S., VINCENZ, C., NI, J., GENTZ, R., and DIXIT, V.M. (1997). I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD95 induced apoptosis. J. Biol. Chem. 272, 17255-17257.
55. MOSIALOS, G., BIRKENBACH, M., YALAMANCHILI, R., VANARSDALE, T., WARE, C., and KIEFF, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumors necrosis factor receptor family. Cell 80, 389-399.
56. SCREATON, G.R., XU, X.-N., OLSEN, A.L., COWPER, A.E., TAN, R., McMICHAEL, A.J., and BELL, J.I. (1997). LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94, 4615-4619.
57. MONGKOLSAPAYA, J., COWPER, A.B., XU, X-N., MORRIS, G., McMICHAEL, A.J., BELL, J.I., and SCREATON, G.R. (1998). Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. J. Immunol. 160, 3-6.
58. SCHIEVELLA, A.R., CHEN, J.H., GRAHAM, J.R., and LIN, L.-L. (1997). MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 272, 12069-12075.
59. BERTIN, J., ARMSTRONG, R.C., OTTILIE, S., MARTIN, D.A., WANG, Y., BANKS, S., WANG, G.-H., SENKEVICH, T.G., ALNEMRI, E.S., MOSS, B., LENARDO, M.J., TOMASELLI, K.J., and COHEN, J.I. (1997). Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94, 1172-1176.
60. HU, S., VINCENZ., C., BULLER, M., and DIXIT, V.M. (1997). A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272, 9621-9624.
61. FERNANDES-ALNEMRI, T., LITWACK, G., and ALNEMRI, E.S. (1995). Mch2, a new member of the apoptotic ced-3/ICE cysteine protease gene family. Cancer Res. 55, 2737-2742.
62. FERNANDES-ALNEMRI, T., TAKAHASHI, A., ARMSTRONG, R., KREBS, J., FRITZ, L., TOMASELLI, K.J., WANG, L., YU, Z., CROCE, C.M., SALVESON, G., EARNSHAW, W.C., LITWACK, G., and ALNEMRI, E.S. (1995) Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55, 6045-6052.
63. FERNANDES-ALNEMRI, T., ARMSTRONG, R.C., KREBS, J., SRINIVASULA, S.M., WANG, L., BULLRICH, F., FRITZ, L.C., TRAPANI, J.A., TOMASELLI, K.J., LITWACK, G., and ALNEMRI, E.S. (1996). In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA 93, 7464-7469.
64. SRINIVASULA, S.M., AHMAD, M., FERNANDES-ALNEMRI, T., LITWACK, G., and ALNEMRI, E.S. (1996). Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 93, 14486-14491.
65. SRINIVASULA, S.M., FERNANDES-ALNEMRI, T., ZANGRILLI, J., ROBERTSON, N., ARMSTRONG, R.C., WANG, L., TRAPANI, J.A., TOMASELLI, K.J., LITWACK, G., and ALNEMRI, E.S. (1996). The Ced-3/interleukin 1β converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2α are substrates for the apoptotic mediator CPP32. J. Biol. Chem. 271, 27099-27106.
66. BOLDIN, M.P., VARFOLOMEEV, E.E., PANCER, Z., METT, I.L., CAMONIS, J.H., and WALLACH, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
67. DUAN, H., and DIXIT, V.M. (1997). RAIDD is a new "death" adaptor molecule. Nature 385, 86-89.
68. ANDERSON, D.M., MARASKOVSKY, E., BILLINGSLEY, W.L., DOUGALL, W.C., TOMETSKO. M.E., ROUX, E.R., TEEPE, M.C., DUBOSE, R.F., COSMAN, D., and GALIBERT, L. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390, 175-179.
69. STANGER, B.Z., LEDER, P., LEE, T.-H., KIM, E., and SEED, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 573-523.
70. OKURA, T., GONG, L., KAMITANI, T., WADA, T., OKURA, I., WEI, C.-F., CHANG, H.-M., and YEH, E.T.H. (1996). Protection against Fas/APO-1- and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157, 4277-4281.
71. CHENG, G., and BALTIMORE, D. (1996). TANK, a co-inducer with TRAF2 of TNF- and CD40-mediated NF-κB activation. Genes Dev. 10, 963-973.
72. PENNICA, D., NEDWIN, G.E., HAYFLICK, J.S., SEEBURG, P.H., DERYNCK, R., PALLADINO, M.A., KOHR, W.J., AGGARWAL, B.B., and GOEDDEL, D.V. (1984). Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724-729.
73. LOETSCHER, H., PAN, Y.-C.E., LAHM, H.-W., GENTZ, R., BROCKHAUS, M., TABUCHI, H., and LESSLAUER, W. (1990). Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61, 357-359.
74. SCHALL, T.J., LEWIS, M., KOLLER, K.J., LEE, A., RICE, G.C., WONG, G.H.W., GATANAGA, T., GRANGER, G.A., LENTZ, R., RAAB, H., KOHR, W.J., and GOEDDEL, D.V. (1990). Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61, 361-370.
75. SMITH, C.A., DAVIS, T., ANDERSON, D., SOLAM, L., BECKMANN, M.P., JERZY, R., DOWER, S.K., COSMAN, D., and GOODWIN, R.G. (1990). A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023.
76. KWON, B.S., TAN, K.B., NI, J., OH, K.O., LEE, Z.H., KIM, K.K., KIM, Y.J., WANG, S., GENTZ, R., YU, G.-L., HARROP, J., LYN, S.D., SILVERMAN, C., PORTER, T.G., TRUNEH, A., and YOUNG, P.R. (1997). A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272, 14272-14276.
77. HSU, H., XIONG, J., and GOEDDEL, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81, 485-504.
78. ROTHE, M., WONG, S.C., HENZEL, W.J., and GOEDDEL, D.V. (1994). A novel family of putative signal transducers associated with cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
79. ROTHE, M., SARMA, V., DIXIT, V.M., and GOEDDEL, D.V. (1995). TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424-1427.
80. BIECHE, I., TOMASETTO, C., REGNIER, C.H., MOOG-LUTZ, C., RIO, M.C., and LIDEREAU, R. (1996). Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer. Cancer Res. 56, 3886-3890.
81. ISHIDA, T.K., TOJO, T., AOKI, T., KOBAYASHI, N., OHISHI, T., WATANABE, T., YAMAMOTO, T., and INOUE, J. (1996). TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93, 9437-9442.
82. ISHIDA, T., MIZUSHIMA, S., AZUMA, A., KOBAYASHI, N., TOJO, T., SUZUKI, K., AIZAWA, S., WATANABE, T., MOSIALOS, G., KIEFF, E., YAMAMOTO, T., and INOUE, J. (1996). Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745-28748.
83. CAO, Z., XIONG, J., TAKEUCHI, M., KURAMA, T., and GOEDDEL, D.V. (1996). TRAF6 is a signal transducer for interleukin-1. Nature 383, 443-446.
84. WILEY, S.R., SCHOOLEY, K., SMOLAK, P.J., DIN, W.S., HUANG, C.-P., NICHOLL, J.K., SUTHERLAND, G.R., SMITH, T.D., RAUCH, C., SMITH, C.A., and GOODWIN, R.G. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-682.
85. WALCZAK, H., DEGLI-ESPOSTI, M.A., JOHNSON, R.S., SMOLAK, P.J., WAUGH, J.Y., BOIANI, N., TIMOUR, M.S., GERHART, M.J., SCHOOLEY, K.A., SMITH, C.A., GOODWIN, R.G., and RAUCH, C.T. (1997). TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16, 5386-5397.
86. DEGLI-ESPOSTI, M.A., DOUGALL, W.C., SMOLAK, P.J., WAUGH, J.Y., SMITH, C.A., and GOODWIN, R.G. (1997). The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7, 813-820.
87. DEGLI-ESPOSTI, M.A., SMOLAK, P.J., WALCZAK, H., WAUGH, J., HUANG, C.-P., DUBOSE, R.F., GOODWIN, R.G., and SMITH, C.A. (1997). Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186, 1165-1170.
88. BODMER, J.-L., BURNS, K., SCHNEIDER, P., HOFMANN, K., STEINER, V., THOME, M., BORNARD, T., HAHNE, M., SCHROTER, M., BECKER, K., WILSON, A., FRENCH, L.E., BROWNING, J.L., MACDONALD, H.R., and TSCHOPP, J. (1997). TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas (Apo-1/CC95). Immunity 6, 79-105.
89. WONG, B.R., RHO, J., ARRON, J., ROBINSON, E., ORLINICK, J., CHAO, M., KALCHIKOV, S., CAYANI, E., BARTLETT, F.S., III, FRANKEL, W.N., LEE, S.Y., and CHOI, Y. (1997). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272, 25790-25794.
90. SCREATON, G.R., MONGKOLSAPAYA, J., XU, X.-N., COWPER, A.E., McMICHAEL, A.J., and BELL, J.I. (1997). TRICK2, a new alternatively splice receptor that transduces the cytotoxic signal from TRAIL. Curr. Biol. 7, 693-696.
91. PAN, G., NI, J., WEI, Y.-F., YU, G.-L., GENTZ, R., and DIXIT, V.M. (1997). An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277, 815-817.
92. LEE, S.Y., LEE, S.Y., and CHOI, Y. (1997). TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation. J. Exp. Med. 185, 1275-1285.
93. PAN, G., NI, J., YU, G.-L., WEI, Y.-F., and DIXIT, V.M. (1998). TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett. 424, 41-45.
94. FAUCHEU, C., DIU, A., CHAN, A.W.E., BLANCHET, A.M., MIOSSEC, C., HERVE, F., COLLARD-DUTILLEUL, V., GU, Y., ALDAPE, R.A., LIPPKE, J.A., ROCHER, C., SU, M.S.-S., LIVINGSTON, D.J., HERCEND, T., and LALANNE, J.-L. (1995). A novel human protease similar to the interleukin-1β converting enzyme induces apoptosis in transfected cells. EMBO. J. 14, 1914-1922.
95. FAUCHEU, C., BLANCHET, A.M., COLLARD-DUTILLEUL, V., LALANNE, J.L., and DIU-HERCEND, A. (1996). Identification of a cysteine protease closely related to interleukin-1β-converting enzyme. Eur. J. Biochem. 236, 207-213.
96. DEVERAUX, Q.L., TAKAHASHI, R., SALVESEN, G.S., and REED, J.C. (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature 3105, 300-304.
97. KITSON, J., RAVEN, T., JIANG, Y.-P., GOEDDEL, D.V., GILES, K.M., PUN, K.-T., GRINHAM, C.J., BROWN, R., and FARROW, S.N. (1996). A death-domain-containing receptor that mediates apoptosis. Nature 384, 372-375.
98. ITOH, N., and NAGATA, S. (1993). A novel protein domain required for apoptosis. J. Biol. Chem. 268, 10932-10937.
99. TARTAGLIA, L.A., AYRES, T.M., WONG, G.H.W., and GOEDDEL, D.V. (1993). A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853.
100. CAMERINI, D., WALZ, G., LOENEN, W.A.M., BORST, J., and SEED, B. (1991). The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147, 3165-3169.
101. DURKOP, H., LATZA, U., HUMMEL, M., EITELBACH, F., SEED, B., and STEIN, H. (1992). Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68, 421-427.
102. STAMENKOVIC, I., CLARK, E.A., and SEED, B. (1989). A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8, 1403-1410.
103. MALLETT, S., FOSSUM, S., and BARCLAY, A.N. (1990). Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor. EMBO J. 9, 1063-1068.
104. JOHNSON, D., LANAHAN, A., BUCK, C.R., SEHGAL, A., MORGAN, C., MERCER, E., BOTHWELL, M., and CHAO, M. (1986). Expression and structure of the human NGF receptor. Cell 47, 545-554.
105. ZHOU, Z., KIM, S., HURTADO, J., LEE, Z.H., KIM, K.K., POLLOK, K.E., and KWON, B.S. (1995). Characterization of human homologue of 4-1BB ligand and its ligand. Immunol. Lett. 45, 67-73.
106. CROWE, P.D., VANARSDALE, T.L., WALTER, B.N., WARE, C.F., HESSION, C., EHRENFELS, B., BROWNING, J.L., DIN, W.S., GOODWIN, R.G., and SMITH, C.A. (1994). A lymphotoxin-beta-specific receptor. Science 264, 707-710.
107. ALNEMRI, E.S., LIVINGSTON, D.J., NICHOLSON, D.W., SALVESEN, G., THORNBERRY, N.A., WONG, W.W., and YUAN, J. (1996). Human ICE/ced-3 protease nomenclature. Cell 87, 171.
108. ELLIS, H.M., and HORVITZ, H.R. (1986). Genetic control of programmed cell death in the nematode C. elegans. Cell 44, 817-829.
109. TAKAHASHI, A., ALNEMRI, E.S., LAZEBNIK, Y.A., FERNANDES-ALNEMRI, T., LITWACK, G., MOIR, R.D., GOLDMAN, R.D., POIRIER, G.G., KAUFMANN, S.H., and EARNSHAW, W.C. (1996). Cleavage of lamin A by Mch2α but not CPP32: multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA 93, 8395-8400.
110. ENARI, M., SAKAHIRA, H., YOKOYAMA, H., OKAWA, K., IWAMATSU, A., and NAGATA, S. (1998). A caspase-activated DNAse that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50.
111. MEMON, S.A., HOU, J.-Z., MORENO, M.B., and ZACHARCHUK, C.M. (1998). Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins. J. Immunol. 160, 2046-2048.
112. GRIMM, S., STANGER, B.Z., and LEDER, P. (1996). RIP and FADD: two "death domain"-containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc. Natl. Acad. Sci. USA 93, 10923-10927.
113. TING, A.T., PIMENTEL-MUINOS, F.X., and SEED, B. (1996). RIP mediates tumor necrosis factor receptor 1 activation of NF-κB but not Fas/APO-1-initiated apoptosis. EMBO J. 15, 6189-6196.
114. HSU, H., SHU, H.-B., PAN, M.-G., and GOEDDEL, D.V. (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299-308.
115. HSU, H., HUANG, J., SHU, H.-B., BAICHWAL, V., and GOEDDEL, D.V. (1996). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387-396.
116. HELLER, R.A., SONG, K., FAN, N., and CHANG, D.J. (1992). The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70, 47-56.
117. HARIDAS, V., DARNAY, B.J., NATRAJAN, K., HELLER, R., and AGGARWAL, B.B. (1998). Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-κB activation, and c-Jun kinase activation. J. Immunol. 160, 3152-3162.
118. WHITE, C., GRETHER, M.E., ABRAMS, J.M., YOUNG, L., FARRELL, K., and STELLER, H. (1994). Genetic control of programmed cell death in Drosophila. Science 264, 677-63.
119. BONNERT, T.P., GARKA, K.E., PARNET, P., SONODA, G., TESTA, J.R., and SIMS, J.E. (1997). The cloning and characterization of human MyD88: a member of an IL-1 receptor related family. FEBS Lett. 402, 81-84.
120. CAO, Z., UENZEL, W.J., and GAO, X. (1996). IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131.
121. MUZIO, M., NI, J., FENG, P., and DIXIT, V.M. (1997). A novel IRAK/Pelle family member (IRAK-2) and MyD105 are components of the IL-1R signaling complex. Science 278, 1612-1615.
122. LAMBERT, S., YU, H., PRCHAL, J.T., LAWLER, J., RUFF, P., SPEICHER, D., CHEUNG, M.C., KAN, Y.W., and PALEK, J. (1990). cDNA sequence for human erythrocyte ankyrin. Proc. Natl. Acad. Sci. USA 87, 1730-1734.
123. DEISS, L.P., FEINSTEIN, E., BERISSI, H., COHEN, O., and KIMCHI, A. (1995). Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev. 9, 15-30.
124. CHINNAIYAN, A.M., TEPPERT, C.G., SELDIN, M.F., O'ROURKE, K., KISCHKEL, F.C., HELLBARDT, S., KRAMMER, P.H., PETER, M.E., and DIXIT, V.M. (1996). FADD/MORT is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4861-4865.
125. LEE, S.Y., PARK, C.G., and CHOI, Y. (1996). T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183, 669-674.
126. SPEISER, D.E., LEE, S.Y., WONG, B., SANTANA, A.J., KONG, Y.Y., OHASHI, P.S., and CHOI, Y. (1997). A regulatory role of TRAF1 in antigen-induced apoptosis of T cells. J. Exp. Med. 185, 1777-1783.
127. REED, J.C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124, 1-6.
128. RAY, C.A., BLACK, R.A., KRONHEIM, S.R., GREENSTREET, T.A., SLEATH, P.R., SALVESEN, G.S., and PICKUP, D.J. (1992). Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β convening enzyme. Cell 69, 597-604.
129. ROY, N., DEVERAUX, Q.L., TAKAHASHI, R., SALVESEN, G.S., and REED, J.C. (1997). The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific proteases. EMBO J. 16, 6914-6925.